Onyx Biotec Fund Raise of ₹25.38 Cr

Onyx Biotec Other Announcement

Onyx Biotec Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.

Onyx Biotec Open Offer

Onyx Biotec's Committee of Independent Directors met to review the open offer by the identified acquirers to purchase 26% of the company's equity share capital.

Onyx Biotec Open Offer: ₹17.21 Cr

Bhardwaj acquirers launch a ₹172.07 Crore open offer for 26% of Onyx Biotec at ₹36.5 per share. Tendering runs October 13–27, 2026.

Value

₹17.21 Cr

Onyx Biotec Annual General Meeting

Onyx Biotec Limited held its 21st Annual General Meeting on September 28, 2026. The meeting covered standard agenda items including financial statement adoption and director appointments.

Onyx Biotec Annual General Meeting

Onyx Biotec Limited will hold its 21st Annual General Meeting on September 28, 2026, via video conferencing to transact the company's business.

Onyx Biotec Management Change

Onyx Biotec Limited has announced a change in the designation of Mr. Naresh Kumar from Whole-Time Director to Executive Director, effective September 3, 2026.

Shree Pushkar Chemicals & Fertilisers Fund Raise of ₹45 Cr

Shree Pushkar's board approved a preferential issue of 854,060 convertible warrants to Punit Makharia. The issue would raise about Rs.45.00 Crore at Rs.527 per warrant.

Value

₹45.00 Cr

Amba Auto Sales and Services Fund Raise of ₹161.6 Cr

Amba Auto board approved a preferential issue of up to 1.60 crore warrants at Rs 101 each. The issue aggregates Rs 161.60 Crore, subject to shareholder approval.

Value

₹161.6 Cr

Jindal Capital Fund Raise of ₹16.22 Cr

Jindal Capital's board approved a rights issue of 1,08,12,149 shares at Rs.15 each, raising Rs.16.22 Crore. The issue ratio is 3:2, with record date 06 November 2026.

Value

₹16.22 Cr

Rajkot Investment Trust Fund Raise of ₹48 Cr

Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.

Value

₹48.00 Cr

U Y Fincorp Fund Raise of ₹187.2 Cr

U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.

Value

₹187.2 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr